BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33866622)

  • 1. Prenatal exposure to non-steroidal anti-inflammatory drugs and risk of attention-deficit/hyperactivity disorder: A follow-up study in the Norwegian mother, father and child cohort.
    Hjorth S; Lupattelli A; Handal M; Spigset O; Ystrom E; Nordeng H
    Pharmacoepidemiol Drug Saf; 2021 Oct; 30(10):1380-1390. PubMed ID: 33866622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Timing and Duration of Prenatal Analgesic Opioid Exposure With Attention-Deficit/Hyperactivity Disorder in Children.
    Trønnes JN; Lupattelli A; Handal M; Skurtveit S; Ystrom E; Nordeng H
    JAMA Netw Open; 2021 Sep; 4(9):e2124324. PubMed ID: 34524436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Maternal Use of Triptans During Pregnancy With Risk of Attention-Deficit/Hyperactivity Disorder in Offspring.
    Harris GM; Wood M; Ystrom E; Nordeng H
    JAMA Netw Open; 2022 Jun; 5(6):e2215333. PubMed ID: 35657626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Maternal Use of Benzodiazepines and Z-Hypnotics During Pregnancy With Motor and Communication Skills and Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers.
    Lupattelli A; Chambers CD; Bandoli G; Handal M; Skurtveit S; Nordeng H
    JAMA Netw Open; 2019 Apr; 2(4):e191435. PubMed ID: 30951155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Prenatal Exposure to Benzodiazepines and Z-Hypnotics With Risk of Attention-Deficit/Hyperactivity Disorder in Childhood.
    Sundbakk LM; Gran JM; Wood ME; Handal M; Skurtveit S; Nordeng H
    JAMA Netw Open; 2022 Dec; 5(12):e2246889. PubMed ID: 36520439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention-deficit/hyperactivity disorder in children following prenatal exposure to antidepressants: results from the Norwegian mother, father and child cohort study.
    Lupattelli A; Mahic M; Handal M; Ystrom E; Reichborn-Kjennerud T; Nordeng H
    BJOG; 2021 Nov; 128(12):1917-1927. PubMed ID: 33982858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy exposure to organophosphate esters and the risk of attention-deficit hyperactivity disorder in the Norwegian mother, father and child cohort study.
    Choi G; Keil AP; Richardson DB; Daniels JL; Hoffman K; Villanger GD; Sakhi AK; Thomsen C; Reichborn-Kjennerud T; Aase H; Engel SM
    Environ Int; 2021 Sep; 154():106549. PubMed ID: 33910116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organophosphorus Pesticide Exposure at 17 Weeks' Gestation and Odds of Offspring Attention-Deficit/Hyperactivity Disorder Diagnosis in the Norwegian Mother, Father, and Child Cohort Study.
    Hall AM; Thistle JE; Manley CK; Roell KR; Ramos AM; Villanger GD; Reichborn-Kjennerud T; Zeiner P; Cequier E; Sakhi AK; Thomsen C; Aase H; Engel SM
    Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal Exposure to Organophosphorus Pesticides and Preschool ADHD in the Norwegian Mother, Father and Child Cohort Study.
    Manley CK; Villanger GD; Thomsen C; Cequier E; Sakhi AK; Reichborn-Kjennerud T; Herring AH; Øvergaard KR; Zeiner P; Roell KR; Engel LS; Kamai EM; Thistle J; Hall A; Aase H; Engel SM
    Int J Environ Res Public Health; 2022 Jul; 19(13):. PubMed ID: 35805806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal Fiber Intake During Pregnancy and Development of Attention-Deficit/Hyperactivity Disorder Symptoms Across Childhood: The Norwegian Mother, Father, and Child Cohort Study.
    Solberg BS; Kvalvik LG; Instanes JT; Hartman CA; Klungsøyr K; Li L; Larsson H; Magnus P; Njølstad PR; Johansson S; Andreassen OA; Bakken NR; Bekkhus M; Austerberry C; Smajlagic D; Havdahl A; Corfield EC; Haavik J; Gjestad R; Zayats T
    Biol Psychiatry; 2024 May; 95(9):839-848. PubMed ID: 38142720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Child and Parental Characteristics of Medication Use for Attention-Deficit/Hyperactivity Disorder.
    Oerbeck B; Furu K; Zeiner P; Aase H; Reichborn-Kjennerud T; Pripp AH; Overgaard KR
    J Child Adolesc Psychopharmacol; 2020 Sep; 30(7):456-464. PubMed ID: 32672488
    [No Abstract]   [Full Text] [Related]  

  • 13. Prenatal smoking, alcohol and caffeine exposure and maternal-reported attention deficit hyperactivity disorder symptoms in childhood: triangulation of evidence using negative control and polygenic risk score analyses.
    Haan E; Sallis HM; Zuccolo L; Labrecque J; Ystrom E; Reichborn-Kjennerud T; Andreassen O; Havdahl A; Munafò MR
    Addiction; 2022 May; 117(5):1458-1471. PubMed ID: 34791750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of sweetened carbonated beverage consumption during pregnancy and ADHD symptoms in the offspring: a study from the Norwegian Mother, Father and Child Cohort Study (MoBa).
    Kvalvik LG; Klungsøyr K; Igland J; Caspersen IH; Brantsæter AL; Solberg BS; Hartman C; Schweren LJS; Larsson H; Li L; Forthun I; Johansson S; Arias Vasquez A; Haavik J
    Eur J Nutr; 2022 Jun; 61(4):2153-2166. PubMed ID: 35066701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Prenatal Exposure to Benzodiazepines With Development of Autism Spectrum and Attention-Deficit/Hyperactivity Disorders.
    Chen VC; Wu SI; Lin CF; Lu ML; Chen YL; Stewart R
    JAMA Netw Open; 2022 Nov; 5(11):e2243282. PubMed ID: 36413366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse family life events during pregnancy and ADHD symptoms in five-year-old offspring.
    Rosenqvist MA; Sjölander A; Ystrom E; Larsson H; Reichborn-Kjennerud T
    J Child Psychol Psychiatry; 2019 Jun; 60(6):665-675. PubMed ID: 30367686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal Mild Thyroid Hormone Insufficiency in Early Pregnancy and Attention-Deficit/Hyperactivity Disorder Symptoms in Children.
    Modesto T; Tiemeier H; Peeters RP; Jaddoe VW; Hofman A; Verhulst FC; Ghassabian A
    JAMA Pediatr; 2015 Sep; 169(9):838-45. PubMed ID: 26146876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gestational thyroid hormone concentrations and risk of attention-deficit hyperactivity disorder in the Norwegian Mother, Father and Child Cohort Study.
    Engel SM; Villanger GD; Herring A; Nethery RC; Drover SSM; Zoeller RT; Meltzer HM; Zeiner P; Knudsen GP; Reichborn-Kjennerud T; Longnecker MP; Aase H
    Paediatr Perinat Epidemiol; 2023 Mar; 37(3):218-228. PubMed ID: 36482860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal alcohol use during pregnancy and offspring attention-deficit hyperactivity disorder (ADHD): a prospective sibling control study.
    Eilertsen EM; Gjerde LC; Reichborn-Kjennerud T; Ørstavik RE; Knudsen GP; Stoltenberg C; Czajkowski N; Røysamb E; Kendler KS; Ystrom E
    Int J Epidemiol; 2017 Oct; 46(5):1633-1640. PubMed ID: 28449133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal Exposure to Acetaminophen and Risk of ADHD.
    Ystrom E; Gustavson K; Brandlistuen RE; Knudsen GP; Magnus P; Susser E; Davey Smith G; Stoltenberg C; Surén P; Håberg SE; Hornig M; Lipkin WI; Nordeng H; Reichborn-Kjennerud T
    Pediatrics; 2017 Nov; 140(5):. PubMed ID: 29084830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.